TD ASSET MANAGEMENT INC – Regeneron Pharmaceuticals, Inc. Transaction History
TD ASSET MANAGEMENT INC portfolio value:
$63.88M
portfolio value
TD ASSET MANAGEMENT INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +5.78% | 5.04K shares | 12.28M | $688.87 | 92.34K |
Q2 2022 | share | Increase | +7.19% | 5.85K shares | -5.27M | $591.13 | 87.29K |
Q1 2022 | share | Decrease | -0.25% | -203 shares | 5.32M | $698.42 | 81.43K |
Q4 2021 | share | Increase | +2.04% | 1.63K shares | 3.14M | $642.51 | 81.64K |
Q3 2021 | share | Decrease | -0.97% | -780 shares | 1.99M | $605.18 | 80.00K |
Q2 2021 | share | Increase | +2.67% | 2.10K shares | 9.19M | $558.54 | 80.78K |
Q1 2021 | share | Increase | +3.73% | 2.82K shares | 581K | $473.14 | 78.68K |
Q4 2020 | share | Increase | +1.53% | 1.14K shares | -5.17M | $483.11 | 75.85K |
Q3 2020 | share | Increase | +7.57% | 5.25K shares | -1.49M | $559.78 | 74.71K |
Q2 2020 | share | Increase | +13.55% | 8.29K shares | 13.44M | $623.65 | 69.45K |
Q1 2020 | share | Increase | +16.51% | 8.66K shares | 10.15M | $488.29 | 61.16K |
Q4 2019 | share | Decrease | -10.05% | -5.86K shares | 3.52M | $375.48 | 52.49K |
Q3 2019 | share | Increase | +2.92% | 1.65K shares | -1.56M | $277.4 | 58.36K |
Q2 2019 | share | Decrease | -16.13% | -10.91K shares | -10.01M | $313 | 56.71K |
Q1 2019 | share | Increase | +40.72% | 19.56K shares | 9.81M | $410.62 | 67.62K |
Q4 2018 | share | Increase | +5.02% | 2.29K shares | -539K | $373.5 | 48.05K |
Q3 2018 | share | Decrease | -8.02% | -3.98K shares | 1.32M | $404.04 | 45.75K |
Q2 2018 | share | Increase | +3.40% | 1.63K shares | 594K | $344.99 | 49.74K |
Q1 2018 | share | Decrease | -0.79% | -385 shares | -1.66M | $344.36 | 48.10K |
Q4 2017 | share | Decrease | -0.31% | -153 shares | -3.51M | $375.96 | 48.49K |
Q3 2017 | share | Decrease | -6.85% | -3.57K shares | -3.89M | $447.12 | 48.64K |
Q2 2017 | share | Decrease | -18.67% | -11.98K shares | 766K | $491.14 | 52.22K |
Q1 2017 | share | Decrease | -0.63% | -405 shares | 1.16M | $387.51 | 64.21K |
Q4 2016 | share | Decrease | -4.76% | -3.22K shares | -3.55M | $367.09 | 64.61K |
Q3 2016 | share | Decrease | -21.41% | -18.47K shares | -2.87M | $402.02 | 67.84K |
Q2 2016 | share | Decrease | -11.31% | -11.01K shares | -4.93M | $349.23 | 86.32K |
Q1 2016 | share | Decrease | -14.59% | -16.63K shares | -26.78M | $360.44 | 97.33K |